Outcome of medical therapy, repeat intervention, and mitral valve surgery after failed MitraClip therapy
- PDF / 962,247 Bytes
- 8 Pages / 595.276 x 790.866 pts Page_size
- 86 Downloads / 201 Views
ORIGINAL ARTICLE
Outcome of medical therapy, repeat intervention, and mitral valve surgery after failed MitraClip therapy Takayuki Gyoten1 · Sören Schenk1 · Oliver Grimmig1 · Sören Just1 · Dirk Fritzsche1 · Daniel Messroghli2,3,4 Received: 23 March 2020 / Accepted: 16 October 2020 © The Japanese Association for Thoracic Surgery 2020
Abstract Objectives Optimal treatment for residual mitral regurgitation (MR) after MitraClip failure is not clearly defined. We report our clinical experience and discuss treatment options. Methods Between January 2013 and January 2018, 37 patients (75 ± 8.9 years, 46% male) were admitted for symptomatic MR (grade 3.1 ± 0.47) diagnosed after previous MitraClip therapy. Clinical outcome of these patients, who underwent medical therapy alone (n = 8, M-group), repeat MitraClip therapy (n = 8, reMC group), or mitral valve surgery (n = 21, S-group) for residual MR, were retrospectively analyzed. Results Thirty-day survival was 88% (M-group), 100% (reMC-group), and 76% (S-group). The rate of discharge to home was 88% in the reMC-group, better than 38% in the M-group (p = 0.051) and 19% in the S-group (p
Data Loading...
